Solutions For RealSolutions For Real
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Summer Financial Checklist

July 1, 2025

3 Gently Used Cars You Can Still Buy for Under $20,000

July 1, 2025

20 Companies With Permanent Remote Jobs

July 1, 2025
Facebook Twitter Instagram
Trending
  • Summer Financial Checklist
  • 3 Gently Used Cars You Can Still Buy for Under $20,000
  • 20 Companies With Permanent Remote Jobs
  • 8 Things You’re Forgetting to Include in Your Monthly Budget
  • NASA, Netflix Team Up to Live Stream Rocket Launches
  • Mark Zuckerberg Reveals Meta Superintelligence Labs
  • You Don’t Need A Retirement Coach—Or Do You?
  • Cut Costs Not Quality: 5 Grocery Upgrades That Save Money in the Long Run
Tuesday, July 1
Facebook Twitter Instagram
Solutions For RealSolutions For Real
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Solutions For RealSolutions For Real
Home » As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant
Investing

As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant

News RoomBy News RoomAugust 19, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Amid an uptick in COVID-19 hospitalizations, vaccine makers say the updated shots they’ve developed for fall are proving effective against the newer variants that are now circulating widely.

A recent study in mice showed that the updated vaccine from Pfizer Inc.
PFE,
+0.41%
and BioNTech
BNTX,
-2.53%
effectively neutralized a number of omicron XBB variants, including XBB.1.5 and EG.5.1, Pfizer said in a statement Friday. The EG.5 variant, nicknamed Eris, is now the dominant variant in the U.S., according to the Centers for Disease Control and Prevention.

Moderna Inc.
MRNA,
-4.35%,
meanwhile, said Thursday that preliminary clinical-trial data show that its updated COVID-19 shot significantly boosted neutralizing antibodies against EG.5 as well as the Fornax FL 1.5.1 variant that is starting to surge in parts of the U.S.

The news comes as COVID hospitalizations have ticked up 14%, according to the most recent weekly data available from the CDC. The share of emergency-department visits linked to COVID, test-positivity rates and levels in wastewater are also increasing nationally, according to the CDC.

The EG.5 variant, which has shown increased prevalence and immune-escape properties, may cause a rise in cases and potentially become dominant globally, the World Health Organization said in a report last week.

Once the new vaccines are approved by the U.S. Food and Drug Administration, the CDC will recommend who should get them.

A program designed to provide free COVID vaccines to uninsured people, however, may not be fully up and running by the time the updated shots are released. The program, announced by the CDC last month, will provide updated shots to uninsured people through local health departments and federally qualified health centers when those vaccines become available in mid-September, according to the CDC. But contracts are still being negotiated to expand the program into retail pharmacies, the CDC said, so people without insurance coverage may not be able to get free updated shots at pharmacies until mid-October. The contract discussions are moving forward “on an accelerated timeline under federal contracting rules,” the CDC said.

Shares of COVID-vaccine makers on Friday gave back some gains from earlier in the week, as Moderna’s stock fell 4%, BioNTech’s American depositary receipts fell 1.7% and Novavax Inc. shares
NVAX,
-3.12%
fell 3%. Pfizer’s stock gained 0.2%.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Mark Zuckerberg Reveals Meta Superintelligence Labs

Investing July 1, 2025

Try This AI-Powered Stock Picker

Investing June 30, 2025

This One Leadership Move Will Transform Your Team’s Loyalty and Performance

Investing June 20, 2025

Meta Plans to Release New Oakley, Prada AI Smart Glasses

Investing June 18, 2025

Citigroup Gives Employees Two Weeks of Remote Work in August

Investing June 11, 2025

Meet a Swift Student Challenge Winner Attending Apple’s WWDC

Investing June 10, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

3 Gently Used Cars You Can Still Buy for Under $20,000

July 1, 20250 Views

20 Companies With Permanent Remote Jobs

July 1, 20250 Views

8 Things You’re Forgetting to Include in Your Monthly Budget

July 1, 20250 Views

NASA, Netflix Team Up to Live Stream Rocket Launches

July 1, 20250 Views
Don't Miss

Mark Zuckerberg Reveals Meta Superintelligence Labs

By News RoomJuly 1, 2025

Meta CEO Mark Zuckerberg, 41, is reshaping the company’s AI efforts to focus on superintelligence,…

You Don’t Need A Retirement Coach—Or Do You?

June 30, 2025

Cut Costs Not Quality: 5 Grocery Upgrades That Save Money in the Long Run

June 30, 2025

10 Creative Ways to Save for a Big Goal (Like a Vacation!)

June 30, 2025
About Us
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Summer Financial Checklist

July 1, 2025

3 Gently Used Cars You Can Still Buy for Under $20,000

July 1, 2025

20 Companies With Permanent Remote Jobs

July 1, 2025
Most Popular

Century 21 CEO optimistic over 2025 real estate market: Here's what buyers 'don't realize'

December 16, 20241 Views

15 Best Paid Survey Sites For Kids

December 12, 20231 Views

Summer Financial Checklist

July 1, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Solutions For Real. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.